SMTL ID : 6t8w.1 (1 other biounit)

Complement factor B in complex with (-)-4-(1-((5,7-Dimethyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic acid

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 2 residues within 4Å: Chain A: G.181, R.185 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:S.182 Water bridges: A:G.181, A:G.181, A:G.181, A:G.181 Salt bridges: A:R.185 SO4.2: 3 residues within 4Å: Chain A: E.71, K.72, R.73 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.72, A:R.73 Salt bridges: A:R.73

1 x MVW: 5,7-dimethyl-4-[[(2~{S})-2-phenylpiperidin-1-yl]methyl]-1~{H}-indole(Non-covalent)

MVW.3: 14 residues within 4Å: Chain A: Y.100, A.190, P.191, T.221, C.222, R.223, S.226, I.244, S.245, W.246, G.247, V.248, V.249, D.250 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:A.190, A:P.191, A:R.223, A:I.244, A:W.246, A:D.250 Hydrogen bonds: A:T.221, A:G.247

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mainolfi, N. et al., Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases. J.Med.Chem. (2020)

Release Date

2020-03-04

Peptides

Complement factor B: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
AAA

Complement factor B

Related Entries With Identical Sequence